Home
ACR PRACTICE PARAMETER FOR THE PERFORMANCE OF SCREENING AND DIAGNOSTIC MAMMOGRAPHY
Revised 2023 (Resolution 10)
PREAMBLE
I. INTRODUCTION
II. INDICATIONS AND CONTRAINDICATIONS
A. Screening Mammography in Cisgender Females [3,16-18]
II. INDICATIONS AND CONTRAINDICATIONS
B. Screening Mammography in Transgender Patients
II. INDICATIONS AND CONTRAINDICATIONS
C. Diagnostic Mammography
III. QUALIFICATIONS AND RESPONSIBLITIES OF PERSONNEL
IV. SPECIFICATIONS OF THE EXAMINATION
A. Screening Mammography
IV. SPECIFICATIONS OF THE EXAMINATION
B. Diagnostic Mammography
IV. SPECIFICATIONS OF THE EXAMINATION
C. Request for Diagnostic Mammography
IV. SPECIFICATIONS OF THE EXAMINATION
D. Image Labeling
IV. SPECIFICATIONS OF THE EXAMINATION
E. Markers
IV. SPECIFICATIONS OF THE EXAMINATION
F. Viewing Issues
IV. SPECIFICATIONS OF THE EXAMINATION
G. Double Reading and Computer-Aided Detection
IV. SPECIFICATIONS OF THE EXAMINATION
H. Image Retention in Accordance with MQSA Regulations
IV. SPECIFICATIONS OF THE EXAMINATION
I. Comparison with Prior Beast Imaging Studies
IV. SPECIFICATIONS OF THE EXAMINATION
J. Mobile and Telemammography Settings
V. DOCUMENTATION
A. Documentation: Mammogram Report
V. DOCUMENTATION
B. Communication of Mammography Results to Health Care Providers
[3]
V. DOCUMENTATION
C. Communication of Mammography Results to Patients
VI. EQUIPMENT SPECIFICATIONS
VII. RADIATION SAFETY IN IMAGING
VIII. QUALITY CONTROL AND IMPROVEMENT, SAFETY, INFECTION CONTROL, AND PATIENT EDUCATION
A. General
VIII. QUALITY CONTROL AND IMPROVEMENT, SAFETY, INFECTION CONTROL, AND PATIENT EDUCATION
B. Quality Control
VIII. QUALITY CONTROL AND IMPROVEMENT, SAFETY, INFECTION CONTROL, AND PATIENT EDUCATION
C. Radiation Dose
VIII. QUALITY CONTROL AND IMPROVEMENT, SAFETY, INFECTION CONTROL, AND PATIENT EDUCATION
D. Medical Outcomes Audit
ACKNOWLEDGEMENTS
REFERENCES